Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundPatients with acute promyelocytic leukemia (APML) undergoing induction therapy are severely immunocompromised…
Browsing: Uncategorized
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundMRSA and PRSP resistance has surged over 30 years, threatening clinical outcomes;…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDown syndrome (DS), caused by trisomy 21, is characterized by chronic oxidative…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundBuprofezin, a thiadiazine insecticide globally recognized as a molting inhibitor, is widely…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare yet debilitating neuropathy characterized…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDoxorubicin (DOX), an anthracycline-based chemotherapeutic agent, has been widely used as a…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundOsteoarthritis (OA) is the most common form of arthritis affecting the elderly…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Background/PurposeAlzheimer’s disease (AD) is a long-term neurodegenerative condition that leads to the…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundChronic diseases present a significant health risk, and global medication adherence for…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundTraditional teaching methods can pose challenges for learners, particularly when it comes…